Michael Sofia, the co-discoverer of Sovaldi (sofosbuvir, Gilead Sciences Inc.), was one of three researchers to win a Lasker-DeBakey Clinical Medical Research Award last week. The Lasker Foundation honored Sofia, along with the University of Heidelberg's Ralf Bartenschlager and Rockefeller University's Charles Rice, "for development of a system to study the replication of the virus that causes hepatitis C and for use of this system to revolutionize the treatment of this chronic, often lethal disease."